SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies (OPEN) is currently trending due to recent announcements aimed at significantly lowering mortgage rates and boosting the broader housing market. This news has ignited strong community optimism, with many anticipating a substantial increase in transaction volume and a potential short squeeze for the real estate technology stock. Despite ongoing discussions about company fundamentals and potential warrant dilution, a prevailing bullish sentiment suggests a significant upside for OPEN within the revitalized housing sector.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending following its announcement of strengthening its balance sheet by converting convertible notes into equity, aiming to eliminate corporate-level indebtedness and reduce future dilution concerns. This development has ignited fervent discussions among investors, with many anticipating a massive short squeeze due to high cost-to-borrow and limited share availability, drawing comparisons to past volatile movers. Conversely, a skeptical segment highlights the company's history of volatility and lack of revenue, fostering a highly debated and speculative environment around the stock.

Polygon

Polygon is actively trending amid significant discussion surrounding its utility and institutional adoption, with reports of BlackRock investments and J.P. Morgan leveraging its DeFi capabilities, alongside integrations with platforms like Instagram. The community is eagerly debating a potential return to the familiar MATIC ticker, balancing Polygon's ongoing technical advancements as a leading Ethereum Layer 2 solution with strong brand recognition. This confluence of major partnerships and an internal brand identity discussion is fueling widespread conversation.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is a focal point of market conversation, driven by anticipation surrounding a crucial Supreme Court ruling on tariffs and the upcoming jobs report, both poised to influence broader market sentiment. Community chatter highlights intense price action around the 620 level, with many traders perceiving "algo fuckery" and "manipulation" as the ETF appears to be coiling for a significant move. This environment of policy uncertainty and economic data has fueled divided opinions on QQQ's near-term direction.

Bakkt Holdings, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt Holdings was founded in 2018 and is headquartered in New York, NY.

Bakkt Holdings Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is drawing attention due to strategic moves, including a partnership to expand its digital asset infrastructure in the U.S. and an investment to establish a regulated gateway into the Indian market. The community is actively discussing these global growth opportunities, alongside speculation around stablecoin adoption and potential short squeezes, while some investors express frustration over past volatility and the desire for more frequent business updates.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is a focal point as the market awaits a key Supreme Court ruling on tariffs and the latest jobs data, with community discussion fiercely debating their potential for market-moving volatility. Adding to the churn, recent administration directives on mortgage bonds are also fueling speculation, as investors navigate a complex landscape of economic signals and political influence.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending due to reports that its subsidiary, Airobotics, has been selected as the prime contractor for Israel's Eastern Border Security Barrier project, a significant development in autonomous defense systems. The community is highly bullish, comparing ONDS to Palantir and anticipating substantial growth driven by increasing defense budgets and the company's strategic positioning in the rapidly evolving drone and AI sector.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is gaining traction following its prominent role in the "MEMES ARE BACK" X Spaces event hosted by @Cryptotwits, drawing significant community attention. Enthusiasts are consistently bullish, driving conversation around the "KENDU SENDU" mantra and emphasizing the project's unique real-world presence through products like Kendu Spice and Kendu Energy drinks. This relentless community building and expansion across multiple blockchain networks signal strong potential for growth and continued visibility.

Exodus Movement, Inc. develops blockchain asset investors platform to secure, exchange and manage wealth inside one application. The company was founded by Daniel Castagnoli and Jon Paul Richardson in 2015 and is headquartered in Omaha, NE.

Exodus Movement Inc - Ordinary Shares - Class A

Exodus Movement is trending as investors focus on its robust, debt-free balance sheet, solidified by a strategic loan repayment to Galaxy Digital. The community is actively discussing its perceived undervaluation and significant potential from expanding Web3 services and stablecoin payment capabilities, including a key partnership with MetaMask, all set to capitalize on strong crypto market momentum and a growing demand for self-custody solutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vishwas Seshadri Sells 25,000 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 25,000 shares of the stock in a transaction that occurred on Monday, December 29th. The shares were sold at an...

Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) have been given an average rating of "Moderate Buy" by the five analysts that are presently covering the stock, MarketBeat reports...

Abeona Therapeutics (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 25,000 Shares

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 25,000 shares of the company's stock in a transaction on Monday, December 29th. The stock was sold at an average...

Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO

Boone Capital Management LLC acquired a new stake in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the second quarter, according to its most recent disclosure with the...

Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving Average - Time to Sell?

Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Below 200-Day Moving Average - What's Next...

ABEO FY2025 EPS Forecast Lifted by Cantor Fitzgerald

Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Cantor Fitzgerald raised their FY2025 EPS estimates for Abeona Therapeutics in a report released on Tuesday, November 25th. Cantor Fitzgerald...

Mark Alvino Sells 15,000 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 15,000 shares of the firm's stock in a transaction on Thursday, November 13th. The stock was sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut Abeona Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 15,000 Shares

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 15,000 shares of the firm's stock in a transaction dated Thursday, November 13th. The stock was sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Posts Quarterly Earnings Results

Abeona Therapeutics (NASDAQ:ABEO - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.10) EPS for the quarter, topping analysts...

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

ABEO
Abeona Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ABEO News

ABEOAbeona Therapeutics Inc